Advanced search
Publication Cover
Leukemia & Lymphoma Volume 9, 1993 - Issue 1-2
Submit an article Journal homepage
12
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Is Recombinant Human Erythropoietin Treatment in Myelodysplastic Syndromes Worthwhile?

M. A. Aloe Spiriti Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy
,
M. C. Petti Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy
,
R. Latagliata Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy
,
G. Avvisati Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy
,
C. De Gregoris Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy
,
S. Proia Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy
,
P. Fazi Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy
,
G. Jaalouk Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy
,
M. Mancini Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy
,
A. Spadea Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy
,
R. Villa Haematology, Department of Human Biopathology, Cilag Spa, Medical Direction Milano, Italy
&
F. Mandelli Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy
 show all
Pages 79-83 | Received 15 Jun 1992, Published online: 01 Jul 2009

References

  • Appelbaum F. R., Storb B., Ramberg R. E., Shulman H. M., Buckner C. D., Clift R. A., Deeg H. J., Fefer A., Sanders J., Self S., Swiger J., Stewart P., Sullivan K., Witherspoon R., Thomas E. D. Treatment of preleukemic syndromes with marrow transplantation. Blood 1987; 69: 92–96
  • Lai P. H., Everett R., Wang F. F., Arakawa T., Goldwasser E. Structural characterization of human erythropoietin. J. Biol. Chem. 1986; 261: 3116–21
  • Eschbach J. W. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int. 1989; 35: 134–48
  • Ludwig H., Fritz E., Kotzman H., Hocker F., Gisslinger H., Barnas U. Erythropoietin treatment of anemia associated with multiple myeloma. N. Eng. J. Med. 1990; 31: 1693–9
  • Aoki I., Chikazawa H., Higashi K., Ishikawa K. In vitro effects of high titers of recombinant human erythropoietin on the bone marrow erythroid progenitors in patients with aplastic anemia. Jpn. J. Clin. Hematol. 1989; 30: 437–42
  • Bowen D. T., Jacobs A., Mary P., Cotes P. M., Lewis T. C. Serum erythropoietin and erythropoiesis in patients with myelodysplastic syndromes. Eur. J. Haematol. 1990; 44: 30–32
  • Besa E. C., Nathan F., Sylvester L., Catalano P. Erythroid response of severely anemic or transfusion-dependent patients with myelodysplastic syndrome to recombinant human erythropoietin (EPO) does not correlate with baseline serum EPO levels. Blood 1990; 76(Suppl 1)279a
  • Garcia J. F., Ebbe S. N., Hollander L., Cutting H. O., Miller M. E., Cronkite E. P. Radioimmunoassay of erythropoietin: circulating levels in normal and polycytemic human beings. J. Lab. Clin. Med. 1982; 99: 624–35
  • Schuster M. W., Allen S. L., Lichtman S. M., Schulman P., De Marco L. C., Budman D. R., Muuse W. T. The use of erythropoietin in the treatment of myelodysplastic syndrome and myelofibrosis. Proc. Am. Soc. Clin. Oncol. 1990; 789a
  • Hoelzer D., Ganser A., Seipelt G., Ottman O., Hoffken K., Boogaerts M., Verhaef G., Lutz D., Krieger O., De Witte T., Diehl W., Lathan B., Ferrant A., Martiat P., Klausmann M., Ganghl D., Frisch J., Schultz G. Hemopoietic growth factors (HGF) in the treatment of patients with myelodysplastic syndromes. Proc. Am. Soc. Clin. Oncol. 1990; 117a
  • Hellstrom L. E., Birgegard G., Lockner D., Helmers C., Wide L., Ost A. Treatment of myelodysplastic syndromes with recombinant human erythropoietin. Blood 1990; 76(Suppl 1)279a
  • Schouten H. C., Vellenga E., Van Rhenen D., Wolf J. T. M., Coppens P. J. W., Blishan G. H. Recombinant human erythropoietin (rhEPO) for patients with a myelodysplastic syndrome (MDS). Blood 1990; 76(Suppl 1)317a
  • Van Kamp H., Prinsze-Postema T. C., Kluin Ph. M., Den Ottolander G. J., Willemze R., Fibbe W. E. Effect of subcutaneously-administered human recombinant erythropoietin on erythropoiesis in patients with myelodysptasia. Blood 1990; 76(Suppl 1)170
  • Isnard F., Najman A., Baillou C. (1990) Recombinant human erythropoietin at high dose is effective for the treatment of the anemia of myelodysplastic syndromes without excess of blasts. Proceeding of International Workshop on Myelodysplastic Syndromes, Innsbruck October 1990. 1990
  • Jacobs A. (1990) Erythropoietin in MDS therapy of myelodysplastic syndromes. Proceeding of International Workshop on Myelodysplastic Syndromes. 1990, Innsbruck October 1990.
  • Bessho M., Jinnai I., Matsuda A., Saito M., Hirashima K. Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia. Inter. J. Cell Cloning. 1990; 8: 445–8
  • Rose E. H., Rudnick S. A., Abels R. I., Lessin L., Hoagland H. C., Prchal J., Schuster M. Efficacy and safety of Recombinant Human Erythropoietin (rHuEPO) in anemic patients with myelodysplastic syndromes. Leuk. Res. 1990; 15(Suppl 1)13a
  • Stone R., Demetri G., Bernstein S., Facklam D., Arthur K., Aster J., Kufe D. A phase I-II trial of erythropoietin (Epoetin-b) (EPO) in patients with myelodysplastic syndromes (MDS). Leuk. Res. 1991; 15(Suppl 1)13b
  • Stein R. S., Abels R. I., Krantz S. B. Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes. Blood 1991; 78: 1658–62
  • Dessypris E. N., Graber S. E., Frantz S. B., Stone W. J. Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo. Blood 1988; 72: 2060

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.